155 related articles for article (PubMed ID: 33402491)
21. Hepatic resection in metastatic breast cancer: results and prognostic factors.
Pocard M; Pouillart P; Asselain B; Salmon R
Eur J Surg Oncol; 2000 Mar; 26(2):155-9. PubMed ID: 10744935
[TBL] [Abstract][Full Text] [Related]
22. Ten-Year Survival after Liver Resection for Breast Metastases: A Single-Center Experience.
Ercolani G; Zanello M; Serenari M; Cescon M; Cucchetti A; Ravaioli M; Del Gaudio M; D'Errico A; Brandi G; Pinna AD
Dig Surg; 2018; 35(4):372-380. PubMed ID: 29393171
[TBL] [Abstract][Full Text] [Related]
23. The Impact on the Long-term Outcomes of Hormonal Status After Hepatic Resection for Breast Cancer Liver Metastases.
Bacalbasa N; Balescu I; Ilie V; Florea R; Sorop A; Brasoveanu V; Brezean I; Vilcu M; Dima S; Popescu I
In Vivo; 2018; 32(5):1247-1253. PubMed ID: 30150452
[TBL] [Abstract][Full Text] [Related]
24. Comparison of hepatic resection and systemic treatment of breast cancer liver metastases: A propensity score matching study.
Feng Y; He XG; Zhou CM; Zhang QY; Huang SY; Li Z; Zhang YF; Pan Q; Ji Y; Zheng Y; Shao ZM; Wang L
Am J Surg; 2020 Oct; 220(4):945-951. PubMed ID: 32145919
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors for longer disease free survival and overall survival after surgical resection of isolated liver metastasis from breast cancer.
Zegarac M; Nikolic S; Gavrilovic D; Jevric M; Kolarevic D; Nikolic-Tomasevic Z; Kocic M; Djurisic I; Inic Z; Ilic V; Santrac N
J BUON; 2013; 18(4):859-65. PubMed ID: 24344009
[TBL] [Abstract][Full Text] [Related]
26. Chronological occurrence of PI3KCA mutations in breast cancer liver metastases after repeat partial liver resection.
Ruiz A; Sebagh M; Saffroy R; Allard MA; Bosselut N; Hardoin G; Vasseur J; Hamelin J; Adam R; Morère JF; Lemoine A
BMC Cancer; 2019 Feb; 19(1):169. PubMed ID: 30795751
[TBL] [Abstract][Full Text] [Related]
27. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
[TBL] [Abstract][Full Text] [Related]
28. Appraisal of disease-specific benefits of minimally invasiveness in surgery of breast cancer liver metastases.
Ratti F; Serenari M; Zanello M; Prosperi E; Cipriani F; Ercolani G; Jovine E; Cescon M; Aldrighetti L
J Surg Oncol; 2019 Dec; 120(7):1169-1176. PubMed ID: 31502270
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer liver metastases: systematic review and time to event meta-analysis with comparison between available treatments.
Rangarajan K; Lazzereschi L; Votano D; Hamady Z
Ann R Coll Surg Engl; 2023 Apr; 105(4):293-305. PubMed ID: 35175853
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors and survival according to tumor subtype in newly diagnosed breast cancer with liver metastases: A competing risk analysis.
Chen QF; Huang T; Shen L; Wu P; Huang ZL; Li W
Mol Clin Oncol; 2019 Sep; 11(3):259-269. PubMed ID: 31396386
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of surgical resection for gastric cancer liver metastases: a retrospective analysis.
Kawahara K; Makino H; Kametaka H; Hoshino I; Fukada T; Seike K; Kawasaki Y; Otsuka M
World J Surg Oncol; 2020 Feb; 18(1):41. PubMed ID: 32093729
[TBL] [Abstract][Full Text] [Related]
32. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
[TBL] [Abstract][Full Text] [Related]
33. Receptor conversion and survival in breast cancer liver metastases.
Sundén M; Norgren S; Lundqvist R; Andersson A; Sund M; Hemmingsson O
Breast Cancer Res; 2023 Sep; 25(1):105. PubMed ID: 37705026
[TBL] [Abstract][Full Text] [Related]
34. Surgical management of breast cancer liver metastases.
Sabol M; Donat R; Chvalny P; Dyttert D; Palaj J; Durdik S
Neoplasma; 2014; 61(5):601-6. PubMed ID: 25244979
[TBL] [Abstract][Full Text] [Related]
35. Surgical therapy for breast cancer liver metastases.
Terata K; Imai K; Wakita A; Sato Y; Motoyama S; Minamiya Y
Transl Cancer Res; 2020 Aug; 9(8):5053-5062. PubMed ID: 35117871
[TBL] [Abstract][Full Text] [Related]
36. Hepatic resection for metastatic breast cancer: a systematic review.
Chua TC; Saxena A; Liauw W; Chu F; Morris DL
Eur J Cancer; 2011 Oct; 47(15):2282-90. PubMed ID: 21741832
[TBL] [Abstract][Full Text] [Related]
37. [Is liver resection or radiofrequency ablation indicated in breast carcinoma metastases?].
Treska V; Skalický T; Fínek J; Kormunda S; Topolcan O; Sutnar A; Neprasová P; Sůvová B
Rozhl Chir; 2004 Apr; 83(4):173-7. PubMed ID: 15216686
[TBL] [Abstract][Full Text] [Related]
38. Salvage RFA in patients with intrahepatic recurrence after major hepatic surgery for colorectal cancer liver metastases: mid-term outcome.
Zimmermann M; Pedersoli F; Schulze-Hagen M; Lurje G; Isfort P; Kuhl C; Bruners P
Eur Radiol; 2020 Feb; 30(2):1221-1227. PubMed ID: 31493210
[TBL] [Abstract][Full Text] [Related]
39. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience.
Rose DM; Essner R; Hughes TM; Tang PC; Bilchik A; Wanek LA; Thompson JF; Morton DL
Arch Surg; 2001 Aug; 136(8):950-5. PubMed ID: 11485537
[TBL] [Abstract][Full Text] [Related]
40. Surgical Management of Breast Cancer Liver Metastasis.
Rahnemai-Azar AA; Selby LV; Lustberg MB; Pawlik TM
Surg Oncol Clin N Am; 2021 Jan; 30(1):27-37. PubMed ID: 33220807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
